RACHELLE BARTEL: Open Payments
NPI 1700135860 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 115 payments from 8 companies in 2025. Trend: 2023 $2,128 · 2024 $1,345 · 2025 $2,029
Food & beverage: $2,029
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $409 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $316 |
| Otsuka America Pharmaceutical, Inc. | 15 | $313 |
| Alkermes, Inc. | 18 | $272 |
| Teva Pharmaceuticals USA, Inc. | 17 | $256 |
| Lundbeck LLC | 7 | $167 |
| Vanda Pharmaceuticals Inc. | 13 | $150 |
| ABBVIE INC. | 10 | $146 |
Products named: REXULTI, COBENFY, CAPLYTA, ARISTADA, AUSTEDO XR, HETLIOZ, VRAYLAR, ABILIFY MAINTENA.
Industry payments across KS — which companies pay providers there.
